Shengcai Zhu
Papers
1
Total Citations
11
H-Index
1
About
Shengcai Zhu is a pioneering urologic surgeon whose research focuses on advancing robotic-assisted surgical techniques, particularly for upper tract urothelial carcinoma. His major contributions center on evaluating the clinical efficacy and safety of emerging robotic platforms, most notably through the first multicenter prospective randomized controlled trial comparing the KangDuo Surgical Robot-01 (KD-SR-01) system against the established da Vinci system for robot-assisted radical nephroureterectomy (RARNU). This landmark 2024 study, which has already garnered 11 citations, provides critical evidence that the domestically developed KD-SR-01 system is a safe and effective alternative to the da Vinci platform, potentially expanding access to minimally invasive surgery. Zhu’s work directly addresses the global need for cost-effective robotic surgical solutions without compromising patient outcomes. By rigorously assessing perioperative metrics, complication rates, and oncologic results, he is helping to shape the future of robotic urology. His research not only validates new technologies but also informs surgical decision-making, making him a key figure in the transition toward more accessible robotic surgery.
Research Focus
Key Achievements
Top Papers
- 1